Microbix Biosystems Inc T.MBX

Alternate Symbol(s): MBXBF

Healthcare Biotechnology

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.

TSX:MBX - Post by User

Microbix Biosystems Inc

Bullboard Posts

Post by carcarneedon May 02, 2011 7:49pm

346 Views

Post# 18520117

Next week MBX can get 2nd quarter

For the quarter ended December 31, 2010, Microbix reported revenues of $812,694, 34% decrease from $1,226,538 for the same period in 2009. Next week maybe can get 2nd quarter, hope ,only hope show positive result. who know? maybe somebody kown already? like "Anonymous 001" this kind of people keep selling means........

Bullboard Posts

Cannara reports record growth and profitability in Q4 2023